Genomics

Dataset Information

0

Profile of rolipram treated B-CLL, normal B, and normal T cells


ABSTRACT: PDE4 inhibitors, which activate cAMP signaling by reducing cAMP catabolism, are known to induce apoptosis in B lineage chronic lymphocytic leukemia (CLL) cells but not normal human T cells. The explanation for such differential sensitivity remains unknown. Here, we report studies contrasting the response to PDE4 inhibitor treatment in CLL cells and normal human T and B cells. Affymetrix gene chip analysis in the three cell populations following treatment with the PDE4 inhibitor rolipram identified a set of up-regulated transcripts with unusually high fold-changes in the CLL samples, several of which are likely part of compensatory negative feedback loops. The high fold-change were due to low basal transcript levels in CLL cells, suggesting that cAMP-mediated signaling may be unusually tightly regulated in this cell type. Keywords: drug response

ORGANISM(S): Homo sapiens

PROVIDER: GSE13987 | GEO | 2009/03/01

SECONDARY ACCESSION(S): PRJNA112481

REPOSITORIES: GEO

Similar Datasets

| E-GEOD-13987 | biostudies-arrayexpress
2013-08-29 | GSE50042 | GEO
2011-05-06 | GSE26526 | GEO
2009-09-10 | GSE18026 | GEO
2022-03-19 | GSE198992 | GEO
| E-GEOD-76546 | biostudies-arrayexpress
| E-GEOD-69134 | biostudies-arrayexpress
2024-01-29 | GSE231799 | GEO
| E-GEOD-26526 | biostudies-arrayexpress
2016-07-01 | GSE76546 | GEO